{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388846194344064.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1101/lm.77104"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1101/lm.77104"}}],"dc:title":[{"@value":"Sleep, dreams, and memory consolidation: The role of the stress hormone cortisol"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>We discuss the relationship between sleep, dreams, and memory, proposing that the content of dreams reflects aspects of memory consolidation taking place during the different stages of sleep. Although we acknowledge the likely involvement of various neuromodulators in these phenomena, we focus on the hormone cortisol, which is known to exert influence on many of the brain systems involved in memory. The concentration of cortisol escalates over the course of the night's sleep, in ways that we propose can help explain the changing nature of dreams across the sleep cycle.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388846194344064","@type":"Researcher","foaf:name":[{"@value":"Jessica D. Payne"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846194344065","@type":"Researcher","foaf:name":[{"@value":"Lynn Nadel"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10720502"},{"@type":"EISSN","@value":"15495485"}],"prism:publicationName":[{"@value":"Learning & Memory"}],"dc:publisher":[{"@value":"Cold Spring Harbor Laboratory"}],"prism:publicationDate":"2004-11","prism:volume":"11","prism:number":"6","prism:startingPage":"671","prism:endingPage":"678"},"reviewed":"false","url":[{"@id":"https://syndication.highwire.org/content/doi/10.1101/lm.77104"}],"createdAt":"2004-12-02","modifiedAt":"2024-01-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390001205257708032","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Report of a case with the improvement of the psychic symptoms since three days after switching from betamethasone to prednisolone-The evaluation by POMS"},{"@language":"ja","@value":"ベタメタゾンからプレドニゾロンへ変更後３日目より精神症状が改善した１症例‐ＰＯＭＳを用いた評価"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1101/lm.77104"},{"@type":"CROSSREF","@value":"10.2512/jspm.5.332_references_DOI_QSFVuRDlnoBxC9uehQ7Pg350DLP"}]}